Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Martinique Science Reporter.
Press releases published on July 18, 2025
Mint Miner Launches Cloud Mining™: Free Bonuses and Guaranteed Crypto Returns for Everyone
GlobeNewswire
·
July 18, 2025
New York City, NY, July 18, 2025 (GLOBE NEWSWIRE) -- Mint Miner, a leading global digital asset infrastructure provider, today officially launched its next-generation Cloud Mining™ platform, making it easy to earn cryptocurrencies without technical …
SoulGen Launches Revolutionary Image to Video AI Platform with Industry-Leading Character Consistency
GlobeNewswire
·
July 18, 2025
HONG KONG, July 18, 2025 (GLOBE NEWSWIRE) -- SoulGen, a leading artificial intelligence company specializing in image to video AI technology, today announced the commercial launch of its proprietary platform that transforms static images into dynamic, …
Hivello’s HVLO Token Now Available in Binance Mobile App
GlobeNewswire
·
July 18, 2025
LONDON and AMSTERDAM, July 18, 2025 (GLOBE NEWSWIRE) -- Hivello, a DePIN aggregator that enables users to earn by monetizing idle (computing) resources across multiple DePINs (Decentralized Physical Infrastructure Networks), announces a significant …
Trogenix Bolsters Clinical Research Team with Appointment of Atif Abbas as Chief Medical Officer and Carolyn Edwards as Vice President, Research & Development
GlobeNewswire
·
July 18, 2025
Trogenix Bolsters Clinical Research Team with Appointment of Atif Abbas as Chief Medical Officer and Carolyn Edwards as Vice President, Research …
Press Release: Sanofi completes acquisition of Blueprint Medicines
GlobeNewswire
·
July 18, 2025
Sanofi completes acquisition of Blueprint Medicines Paris, July 18, 2025. Sanofi today announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint), adding to its portfolio a commercialized medicine, a promising pipeline, and …
Communiqué de presse : Sanofi finalise l’acquisition de Blueprint Medicines
GlobeNewswire
·
July 18, 2025
Sanofi finalise l’acquisition de Blueprint Medicines Paris, le 18 juillet 2025. Sanofi annonce aujourd’hui la finalisation de l’acquisition de Blueprint Medicines Corporation (Blueprint). La nouvelle entreprise ajoute au portefeuille de Sanofi des …
FACT CHECK: Frequency Holdings YCRM Issues Clarification On Procedural Judgment; No Liability to Company, Litigation Exposure Remains for Luciano Aguayo
GlobeNewswire
·
July 18, 2025
CHICAGO, July 17, 2025 (GLOBE NEWSWIRE) -- Frequency Holdings Inc. (OTC: YCRM), a Nevada public company, issues this clarification following a press release distributed on July 17, 2025, by Luciano Aguayo, defendant in the original and now-defunct lawsuit …
Aduro Clean Technologies tritt der Plastics Industry Association und der Polystyrene Recycling Alliance zur Förderung der Branchenzusammenarbeit im Bereich Recycling-Innovationen bei
GlobeNewswire
·
July 18, 2025
LONDON, Ontario, July 18, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. („Aduro” oder das „Unternehmen”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), ein Unternehmen für saubere Technologien, das die Kraft der Chemie nutzt, um minderwertige Rohstoffe wie …
Aduro Clean Technologies rejoint la Plastics Industry Association et la Polystyrene Recycling Alliance en vue de favoriser la collaboration entre les industries en matière d’innovation dans le domaine du recyclage
GlobeNewswire
·
July 18, 2025
LONDON, Ontario, 18 juill. 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (ci-après « Aduro » ou la « Société ») (Nasdaq : ADUR) (CSE : ACT) (FSE : 9D5), une société de technologie propre qui recycle chimiquement les matières premières de moindre …
SAPU Bioscience Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients
GlobeNewswire
·
July 18, 2025
Data supports further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted approach in pancreatic ductal adenocarcinoma. SAN DIEGO, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Sapu Biosciences, LLC (Sapu), a wholly owned …
Successful Commercial Launch of Ryoncil®
GlobeNewswire
·
July 18, 2025
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross revenue from sales of Ryoncil® (remestemcel-L-rknd) through the first …